Cancer, ivermectin thalidomide and vit D

Summary

In this compelling discussion, the speaker highlights the overlooked benefits of Ivermectin, especially in treating COVID-19 and cancer, arguing that its potential has been unjustly dismissed. They emphasize the critical role of vitamin D in boosting treatment efficacy for cancer patients, showing that those with optimal levels respond better to therapies. Drawing from personal experience and research, the speaker criticizes medical institutions for failing to routinely measure and address vitamin D deficiencies. They also showcase promising results from IMM 101, an immune-modulating therapy, suggesting that integrating immune support with conventional treatments can lead to improved patient outcomes.

Takeaways

• 😀 Ivermectin has proven to be effective in treating COVID-19, particularly in severely ill patients, with no reported deaths from its use.
• 😀 Ivermectin is considered one of the safest drugs available, with lower toxicity compared to common over-the-counter medications like ibuprofen and paracetamol.
• 😀 There is growing evidence suggesting ivermectin’s antiviral and potential anti-cancer properties, with ongoing studies exploring its effectiveness in treating cancer.
• 😀 Ivermectin shares similar mechanisms with other cancer drugs like lenalidomide, which has been successfully used in treating various cancers.
• 😀 The importance of vitamin D in chemotherapy: patients with higher vitamin D levels are more likely to respond positively to cancer treatments.
• 😀 Vitamin D levels should be optimized for cancer patients to improve their immune system function and treatment outcomes.
• 😀 Despite its importance, many cancer treatment centers fail to routinely test for and address low vitamin D levels in patients.
• 😀 IMM101, an immune-modulating treatment, has shown promising survival outcomes for pancreatic cancer patients, especially when paired with optimal vitamin D levels.
• 😀 Standard vitamin D levels recommended by the NHS (50 nmol/L) are too low for cancer patients, with an optimal level of over 100 nmol/L being more effective for treatment response.
• 😀 The speaker emphasizes that vitamin D testing and supplementation should be a routine part of cancer care, but many oncologists overlook it, leaving it to dietitians or secondary consultations.
• 😀 Ivermectin’s safety and low toxicity make it a viable option for treating not only viral infections but also other serious conditions like cancer, with minimal side effects.

Q & A

What is the speaker's view on Ivermectin as a treatment for COVID-19?

The speaker believes that Ivermectin could have been an effective treatment for COVID-19, particularly for severely ill patients. They argue that Ivermectin is safe, has minimal toxicity, and has been used successfully in various contexts, including parasitic infections and cancer research. Despite its dismissal by authorities, the speaker supports its efficacy based on personal experience and patient outcomes.

What does the speaker claim about the safety of Ivermectin compared to other common medications?

The speaker asserts that Ivermectin is safer than common medications like ibuprofen or paracetamol, citing its low toxicity and widespread use across millions of people globally. They also mention its potential benefits in treating conditions like parasitic infections and possibly cancer.

How does Ivermectin potentially work as an anti-cancer agent?

The speaker suggests that Ivermectin works as an anti-cancer agent by targeting multiple cancer pathways, similar to drugs like lenalidomide (derived from thalidomide). This ability to interfere with several cancer mechanisms allows Ivermectin to be administered at non-toxic doses, with the potential for significant anti-cancer activity.

What role does Vitamin D play in the effectiveness of cancer treatments according to the speaker?

The speaker emphasizes that adequate Vitamin D levels are crucial for the success of cancer treatments. They explain that patients with low Vitamin D levels do not respond well to therapies like chemotherapy and immunotherapy. Higher Vitamin D levels have been shown to correlate with better survival and improved response to cancer treatments.

What Vitamin D levels does the speaker recommend for cancer patients?

The speaker recommends maintaining Vitamin D levels above 100 nanomoles per liter for cancer patients, which is significantly higher than the NHS standard of 50 nanomoles per liter. They argue that the standard recommended levels are too low, especially in the context of cancer treatment.

What was the outcome of the IMM101 trial for pancreatic cancer?

The IMM101 trial for pancreatic cancer showed significantly improved survival rates for patients treated with IMM101 in combination with gemcitabine (a chemotherapy drug). Even patients who were too ill for more aggressive treatments responded well, highlighting the potential of IMM101 as an effective treatment.

Why does the speaker believe Ivermectin could complement conventional cancer treatments?

The speaker believes that Ivermectin could complement conventional cancer treatments like chemotherapy and radiation by targeting additional cancer pathways that these treatments miss. This would enhance the overall effectiveness of cancer therapies and improve patient outcomes.

What issue does the speaker highlight regarding Vitamin D testing in cancer centers?

The speaker criticizes cancer centers for not routinely testing Vitamin D levels in patients. They argue that it should be standard practice, as low Vitamin D levels are linked to poor responses to cancer treatments. The speaker believes that this oversight is contributing to unnecessary suffering and financial costs for patients.

What does the speaker say about the resistance to acknowledging the role of Vitamin D in cancer treatment?

The speaker notes significant resistance within the medical community, particularly among oncologists, to acknowledge the role of Vitamin D in cancer treatment. Despite clear evidence linking adequate Vitamin D levels to better treatment outcomes, many oncologists fail to test or correct Vitamin D deficiencies in their patients.

How does the speaker explain the connection between Vitamin D and chemotherapy effectiveness?

The speaker explains that Vitamin D plays a crucial role in the immune system's ability to respond to chemotherapy. They note that patients with low Vitamin D levels tend to be non-responders to chemotherapy, while those with higher levels are more likely to experience positive outcomes. This connection underscores the importance of maintaining optimal Vitamin D levels during cancer treatment.